Literature DB >> 24329550

Role of prostaglandin D2 /CRTH2 pathway on asthma exacerbation induced by Aspergillus fumigatus.

Haixia Liu1, Mingrui Zheng, Jianou Qiao, Yajie Dang, Pengyu Zhang, Xianqiao Jin.   

Abstract

Aspergillus fumigatus is often associated in asthmatic patients with the exacerbation of asthma symptoms. The pathomechanism of this phenomenon has not been fully understood. Here, we evaluated the immunological mechanisms and the role of the prostaglandin D2 / Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2) pathway in the development of Aspergillus-associated asthma exacerbation. We studied the effects of A. fumigatus on airway inflammation and bronchial hyper-responsiveness in a rat model of chronic asthma. Inhalation delivery of A. fumigatus conidia increased the airway eosinophilia and bronchial hyper-responsiveness in ovalbumin-sensitized, challenged rats. These changes were associated with prostaglandin D2 synthesis and CRTH2 expression in the lungs. Direct inflammation occurred in ovalbumin-sensitized, challenged animals, whereas pre-treatment with an antagonist against CRTH2 nearly completely eliminated the A. fumigatus-induced worsening of airway eosinophilia and bronchial hyper-responsiveness. Our data demonstrate that production of prostaglandin D2 followed by eosinophil recruitment into the airways via a CRTH2 receptor are the major pathogenic factors responsible for the A. fumigatus-induced enhancement of airway inflammation and responsiveness.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  Aspergillus fumigatus; CRTH2; airway responsiveness; asthma; eosinophil; prostaglandin D2

Mesh:

Substances:

Year:  2014        PMID: 24329550      PMCID: PMC3992050          DOI: 10.1111/imm.12234

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  79 in total

Review 1.  Host immune defense against Aspergillus fumigatus: insight from experimental systemic (disseminated) infection.

Authors:  I Mirkov; S Stosic-Grujicic; M Kataranovski
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

Review 2.  The link between fungi and severe asthma: a summary of the evidence.

Authors:  D W Denning; B R O'Driscoll; C M Hogaboam; P Bowyer; R M Niven
Journal:  Eur Respir J       Date:  2006-03       Impact factor: 16.671

3.  Aspergillus antigen-induced eosinophil differentiation in a murine model.

Authors:  P S Murali; G Dai; A Kumar; J N Fink; V P Kurup
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

Review 4.  Novel CRTH2 antagonists: a review of patents from 2006 to 2009.

Authors:  Trond Ulven; Evi Kostenis
Journal:  Expert Opin Ther Pat       Date:  2010-10-15       Impact factor: 6.674

Review 5.  Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis.

Authors:  Taylor R T Dagenais; Nancy P Keller
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

6.  Innate antifungal immunity of human eosinophils mediated by a beta 2 integrin, CD11b.

Authors:  Juhan Yoon; Jens U Ponikau; Christopher B Lawrence; Hirohito Kita
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

Review 7.  The roles of the prostaglandin D(2) receptors DP(1) and CRTH2 in promoting allergic responses.

Authors:  R Pettipher
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

8.  Dectin-2 recognition of house dust mite triggers cysteinyl leukotriene generation by dendritic cells.

Authors:  Nora A Barrett; Akiko Maekawa; Opu M Rahman; K Frank Austen; Yoshihide Kanaoka
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

9.  Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation.

Authors:  Lena Uller; Jesper Mosolff Mathiesen; Lisa Alenmyr; Magnus Korsgren; Trond Ulven; Thomas Högberg; Gunnar Andersson; Carl G A Persson; Evi Kostenis
Journal:  Respir Res       Date:  2007-02-28

10.  Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression.

Authors:  S Finotto; G T De Sanctis; H A Lehr; U Herz; M Buerke; M Schipp; B Bartsch; R Atreya; E Schmitt; P R Galle; H Renz; M F Neurath
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

View more
  6 in total

Review 1.  Fungal Exposure and Asthma: IgE and Non-IgE-Mediated Mechanisms.

Authors:  Zhonghua Zhang; Tiina Reponen; Gurjit K Khurana Hershey
Journal:  Curr Allergy Asthma Rep       Date:  2016-11       Impact factor: 4.806

Review 2.  Prostaglandins in asthma and allergic diseases.

Authors:  R Stokes Peebles
Journal:  Pharmacol Ther       Date:  2018-08-03       Impact factor: 12.310

3.  Eosinophils Contribute to Intestinal Inflammation via Chemoattractant Receptor-homologous Molecule Expressed on Th2 Cells, CRTH2, in Experimental Crohn's Disease.

Authors:  Balázs Radnai; Eva M Sturm; Angela Stančić; Katharina Jandl; Sandra Labocha; Nerea Ferreirós; Magdalena Grill; Carina Hasenoehrl; Gregor Gorkiewicz; Gunther Marsche; Ákos Heinemann; Christoph Högenauer; Rudolf Schicho
Journal:  J Crohns Colitis       Date:  2016-02-29       Impact factor: 9.071

4.  CXCR3, CCR5, and CRTH2 Chemokine Receptor Expression in Lymphocytes Infiltrating Thyroid Nodules with Coincident Hashimoto's Thyroiditis Obtained by Fine Needle Aspiration Biopsy.

Authors:  Jan Jiskra; Marie Antošová; Jan Krátký; Hana Vítková; Zdeňka Límanová; Helena Marečková; Eliška Potluková
Journal:  J Immunol Res       Date:  2016-10-31       Impact factor: 4.818

5.  Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies.

Authors:  Paul Ratner; Charles P Andrews; Frank C Hampel; Bruce Martin; Dale E Mohar; Denis Bourrelly; Parisa Danaietash; Sara Mangialaio; Jasper Dingemanse; Abdel Hmissi; Jay van Bavel
Journal:  Allergy Asthma Clin Immunol       Date:  2017-04-04       Impact factor: 3.406

6.  Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trial.

Authors:  Hugo Farne; Nicholas Glanville; Nicholas Johnson; Tata Kebadze; Julia Aniscenko; Eteri Regis; Jie Zhu; Maria-Belen Trujillo-Torralbo; Onn Min Kon; Patrick Mallia; A Toby Prevost; Michael R Edwards; Sebastian L Johnston; Aran Singanayagam; David J Jackson
Journal:  Thorax       Date:  2021-10-29       Impact factor: 9.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.